Deutsche Bank
WHWK

Deutsche Bank’s Whitehawk Therapeutics WHWK Stock Holding History

Deutsche Bank’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
+31,668
New +$132K ﹤0.01% 3382
2023
Q4 		– Sell
-12,268
Closed -$59.4K – 3725
2023
Q3 		$59.4K Hold
12,268
– – ﹤0.01% 3361
2023
Q2 		$83.9K Buy
12,268
+2,887
+31% +$22.4K ﹤0.01% 3347
2023
Q1 		$67.9K Buy
9,381
+2,973
+46% +$31.8K ﹤0.01% 3468
2022
Q4 		$82.2K Buy
6,408
+96
+2% +$1.25K ﹤0.01% 3419
2022
Q3 		$89K Sell
6,312
-971
-13% -$12.8K ﹤0.01% 3383
2022
Q2 		$89K Buy
+7,283
New +$108K ﹤0.01% 3572
2020
Q1 		– Sell
-447
Closed -$4K – 4909
2019
Q4 		$4K Buy
+447
New +$3.73K ﹤0.01% 4715

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's WHWK Position: Q2 2026 in Review

Deutsche Bank opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 31,668 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #3382 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in WHWK as recently as Q3 2023.

Deutsche Bank first reported a position in WHWK in Q4 2019 and has held it in 8 quarters since. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Deutsche Bank held 31,668 shares of Whitehawk Therapeutics worth $145K as of Q2 2026.
  • Whitehawk Therapeutics was a new Deutsche Bank position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3382 holding.
  • Deutsche Bank first reported a position in Whitehawk Therapeutics in Q4 2019 and has held it in 8 quarters since.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.